nodes	percent_of_prediction	percent_of_DWPC	metapath
Ruxolitinib—LTK—tongue—larynx cancer	0.0581	0.0581	CbGeAlD
Ruxolitinib—LTK—mouth—larynx cancer	0.0391	0.0391	CbGeAlD
Ruxolitinib—JAK1—neck—larynx cancer	0.0265	0.0265	CbGeAlD
Ruxolitinib—PLK3—trachea—larynx cancer	0.0208	0.0208	CbGeAlD
Ruxolitinib—PRKCE—thyroid gland—larynx cancer	0.0205	0.0205	CbGeAlD
Ruxolitinib—BMP2K—neck—larynx cancer	0.0199	0.0199	CbGeAlD
Ruxolitinib—RPS6KA6—thyroid gland—larynx cancer	0.0197	0.0197	CbGeAlD
Ruxolitinib—JAK1—epithelium—larynx cancer	0.0181	0.0181	CbGeAlD
Ruxolitinib—RET—neck—larynx cancer	0.0169	0.0169	CbGeAlD
Ruxolitinib—PLK3—thyroid gland—larynx cancer	0.0165	0.0165	CbGeAlD
Ruxolitinib—JAK1—trachea—larynx cancer	0.016	0.016	CbGeAlD
Ruxolitinib—DCLK1—trachea—larynx cancer	0.016	0.016	CbGeAlD
Ruxolitinib—CAMK1D—trachea—larynx cancer	0.0156	0.0156	CbGeAlD
Ruxolitinib—ROCK1—epithelium—larynx cancer	0.0156	0.0156	CbGeAlD
Ruxolitinib—CAMK1—thyroid gland—larynx cancer	0.0154	0.0154	CbGeAlD
Ruxolitinib—DAPK2—trachea—larynx cancer	0.0152	0.0152	CbGeAlD
Ruxolitinib—MARK2—thyroid gland—larynx cancer	0.015	0.015	CbGeAlD
Ruxolitinib—CLK2—trachea—larynx cancer	0.0142	0.0142	CbGeAlD
Ruxolitinib—TAOK2—thyroid gland—larynx cancer	0.0138	0.0138	CbGeAlD
Ruxolitinib—NUAK2—trachea—larynx cancer	0.0128	0.0128	CbGeAlD
Ruxolitinib—PRKCE—lymph node—larynx cancer	0.0128	0.0128	CbGeAlD
Ruxolitinib—JAK3—thyroid gland—larynx cancer	0.0127	0.0127	CbGeAlD
Ruxolitinib—JAK1—thyroid gland—larynx cancer	0.0126	0.0126	CbGeAlD
Ruxolitinib—DCLK1—thyroid gland—larynx cancer	0.0126	0.0126	CbGeAlD
Ruxolitinib—CAMK1D—thyroid gland—larynx cancer	0.0123	0.0123	CbGeAlD
Ruxolitinib—PHKG2—thyroid gland—larynx cancer	0.0123	0.0123	CbGeAlD
Ruxolitinib—PLK1—lymph node—larynx cancer	0.0123	0.0123	CbGeAlD
Ruxolitinib—RPS6KA6—lymph node—larynx cancer	0.0123	0.0123	CbGeAlD
Ruxolitinib—DAPK2—thyroid gland—larynx cancer	0.0121	0.0121	CbGeAlD
Ruxolitinib—STK16—thyroid gland—larynx cancer	0.0119	0.0119	CbGeAlD
Ruxolitinib—HIPK2—thyroid gland—larynx cancer	0.0118	0.0118	CbGeAlD
Ruxolitinib—MKNK2—epithelium—larynx cancer	0.0118	0.0118	CbGeAlD
Ruxolitinib—RET—epithelium—larynx cancer	0.0115	0.0115	CbGeAlD
Ruxolitinib—DAPK3—thyroid gland—larynx cancer	0.0113	0.0113	CbGeAlD
Ruxolitinib—CLK2—thyroid gland—larynx cancer	0.0112	0.0112	CbGeAlD
Ruxolitinib—JAK2—epithelium—larynx cancer	0.0109	0.0109	CbGeAlD
Ruxolitinib—MAP3K7—trachea—larynx cancer	0.0108	0.0108	CbGeAlD
Ruxolitinib—DYRK1A—thyroid gland—larynx cancer	0.0106	0.0106	CbGeAlD
Ruxolitinib—BMPR2—thyroid gland—larynx cancer	0.0106	0.0106	CbGeAlD
Ruxolitinib—TYK2—trachea—larynx cancer	0.0106	0.0106	CbGeAlD
Ruxolitinib—MKNK2—trachea—larynx cancer	0.0104	0.0104	CbGeAlD
Ruxolitinib—PLK3—lymph node—larynx cancer	0.0102	0.0102	CbGeAlD
Ruxolitinib—NUAK2—thyroid gland—larynx cancer	0.0101	0.0101	CbGeAlD
Ruxolitinib—LTK—lymph node—larynx cancer	0.00988	0.00988	CbGeAlD
Ruxolitinib—JAK2—trachea—larynx cancer	0.00961	0.00961	CbGeAlD
Ruxolitinib—CAMK1—lymph node—larynx cancer	0.00957	0.00957	CbGeAlD
Ruxolitinib—CAMK2G—thyroid gland—larynx cancer	0.00946	0.00946	CbGeAlD
Ruxolitinib—BMP2K—thyroid gland—larynx cancer	0.00946	0.00946	CbGeAlD
Ruxolitinib—LRRK2—thyroid gland—larynx cancer	0.00937	0.00937	CbGeAlD
Ruxolitinib—MARK2—lymph node—larynx cancer	0.00929	0.00929	CbGeAlD
Ruxolitinib—MAP3K3—trachea—larynx cancer	0.00926	0.00926	CbGeAlD
Ruxolitinib—TAOK2—lymph node—larynx cancer	0.0086	0.0086	CbGeAlD
Ruxolitinib—MAP3K2—thyroid gland—larynx cancer	0.00859	0.00859	CbGeAlD
Ruxolitinib—MAP3K7—thyroid gland—larynx cancer	0.00851	0.00851	CbGeAlD
Ruxolitinib—TAOK3—trachea—larynx cancer	0.00844	0.00844	CbGeAlD
Ruxolitinib—TYK2—thyroid gland—larynx cancer	0.00836	0.00836	CbGeAlD
Ruxolitinib—MKNK2—thyroid gland—larynx cancer	0.00825	0.00825	CbGeAlD
Ruxolitinib—IRAK1—thyroid gland—larynx cancer	0.00825	0.00825	CbGeAlD
Ruxolitinib—RET—thyroid gland—larynx cancer	0.00804	0.00804	CbGeAlD
Ruxolitinib—JAK3—lymph node—larynx cancer	0.0079	0.0079	CbGeAlD
Ruxolitinib—DCLK1—lymph node—larynx cancer	0.00785	0.00785	CbGeAlD
Ruxolitinib—JAK1—lymph node—larynx cancer	0.00785	0.00785	CbGeAlD
Ruxolitinib—PLK4—lymph node—larynx cancer	0.0078	0.0078	CbGeAlD
Ruxolitinib—CAMK1D—lymph node—larynx cancer	0.00766	0.00766	CbGeAlD
Ruxolitinib—PHKG2—lymph node—larynx cancer	0.00762	0.00762	CbGeAlD
Ruxolitinib—JAK2—thyroid gland—larynx cancer	0.0076	0.0076	CbGeAlD
Ruxolitinib—DAPK2—lymph node—larynx cancer	0.00749	0.00749	CbGeAlD
Ruxolitinib—STK16—lymph node—larynx cancer	0.00737	0.00737	CbGeAlD
Ruxolitinib—HIPK2—lymph node—larynx cancer	0.00733	0.00733	CbGeAlD
Ruxolitinib—MAP3K3—thyroid gland—larynx cancer	0.00733	0.00733	CbGeAlD
Ruxolitinib—DAPK3—lymph node—larynx cancer	0.00704	0.00704	CbGeAlD
Ruxolitinib—CLK2—lymph node—larynx cancer	0.00697	0.00697	CbGeAlD
Ruxolitinib—TAOK3—thyroid gland—larynx cancer	0.00668	0.00668	CbGeAlD
Ruxolitinib—DYRK1A—lymph node—larynx cancer	0.00659	0.00659	CbGeAlD
Ruxolitinib—BMPR2—lymph node—larynx cancer	0.00657	0.00657	CbGeAlD
Ruxolitinib—NUAK2—lymph node—larynx cancer	0.00627	0.00627	CbGeAlD
Ruxolitinib—BMP2K—lymph node—larynx cancer	0.00588	0.00588	CbGeAlD
Ruxolitinib—CAMK2G—lymph node—larynx cancer	0.00588	0.00588	CbGeAlD
Ruxolitinib—LRRK2—lymph node—larynx cancer	0.00582	0.00582	CbGeAlD
Ruxolitinib—MAP3K2—lymph node—larynx cancer	0.00534	0.00534	CbGeAlD
Ruxolitinib—MAP3K7—lymph node—larynx cancer	0.00529	0.00529	CbGeAlD
Ruxolitinib—TYK2—lymph node—larynx cancer	0.00519	0.00519	CbGeAlD
Ruxolitinib—MKNK2—lymph node—larynx cancer	0.00512	0.00512	CbGeAlD
Ruxolitinib—IRAK1—lymph node—larynx cancer	0.00512	0.00512	CbGeAlD
Ruxolitinib—RET—lymph node—larynx cancer	0.005	0.005	CbGeAlD
Ruxolitinib—JAK2—lymph node—larynx cancer	0.00472	0.00472	CbGeAlD
Ruxolitinib—MAP3K3—lymph node—larynx cancer	0.00455	0.00455	CbGeAlD
Ruxolitinib—TAOK3—lymph node—larynx cancer	0.00415	0.00415	CbGeAlD
